U.S. FDA requires slimming injections to add potential risk of blindness, Food and Drug Administration initiates re-evaluation
NAION is a rare ischemic disease of the optic nerve that may cause sudden loss of vision in one eye. However, the U.S. FDA only identifies "potential" risks, and drug users must first […] The U.S. FDA requires slimming injections to add potential blindness risks, and the Food and Drug Administration initiates a re-evaluation> This article was first published in BlockTempo "Dong District Dongzhi - the most influential blockchain news media".
U.S. FDA requires slimming injections to add potential risk of blindness, Food and Drug Administration initiates re-evaluation
NAION is a rare ischemic disease of the optic nerve that may cause sudden loss of vision in one eye. However, the U.S. FDA only identifies "potential" risks, and drug users must first […] The U.S. FDA requires slimming injections to add potential blindness risks, and the Food and Drug Administration initiates a re-evaluation> This article was first published in BlockTempo "Dong District Dongzhi - the most influential blockchain news media".
Read more
